Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Selected Quarterly Financial Data (Unaudited)

Selected Quarterly Financial Data (Unaudited)

12 Months Ended

Dec. 31, 2012

Selected Quarterly Financial Data [Abstract]

Selected Quarterly Financial Data (Unaudited)

18. Selected Quarterly Financial Data (Unaudited)

The following table contains quarterly financial information for fiscal years 2012 and 2011. The Company believes that the following information reflects all normal recurring adjustments necessary for a fair statement of the information for the periods presented.


(in thousands, except per share data)	First Quarter			Second Quarter			Third Quarter			Fourth Quarter
2012
Operating expenses	$	(6,581	)	$	(6,465	)	$	(5,831	)	$	(8,299	)
Other income/(expense)	$	25		$	10		$	(104	)	$	(365	)
Net loss	$	(6,556	)	$	(6,455	)	$	(5,935	)	$	(8,664	)
Basic and diluted net loss per common share	$	(0.35	)	$	(0.34	)	$	(0.24	)	$	(0.36	)

2011
Operating expenses	$	(22,545	)	$	(3,736	)	$	(3,531	)	$	(5,232	)
Other income/(expense)	$	2		$	3		$	166		$	(1,487	)
Net loss	$	(22,543	)	$	(3,733	)	$	(3,365	)	$	(6,719	)
Basic and diluted net loss per common share	$	(4.71	)	$	(0.64	)	$	(0.48	)	$	(0.52	)

- Definition

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

+ References + Details